SB Global Advisers’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$14.3M Hold
12,100,078
1.66% 7
2022
Q3
$24.7M Hold
12,100,078
1.82% 7
2022
Q2
$18.6M Hold
12,100,078
0.88% 7
2022
Q1
$61.1M Hold
12,100,078
1.92% 7
2021
Q4
$75M Buy
+12,100,078
New +$75M 1.49% 7